Over 6 billion yuan will be invested in the development of major new drugs during the 12th Five Year Plan Period
-
Last Update: 2020-04-03
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
On July 17, Ma Hongjian, deputy director of China Biotechnology Development Center of the Ministry of science and technology, said at the 2013 top 100 pharmaceutical conference that the support funds for major new drug development during the 12th Five Year Plan will exceed 6 billion "Major new drug creation" is a large-scale scientific and technological plan in China, aiming to encourage new drug research and development "From 2011 to 2013, about 5 billion yuan of financial support has been used for drug research and development." According to Ma Hongjian, the 12th Five Year Plan will definitely be higher than the 6 billion in the 11th five year plan He also pointed out that in the research and development direction of new drugs supported by the Ministry of science and technology, biological drugs such as new adjuvants for vaccines, therapeutic vaccines and recombinant clotting factor products were named as the key research and development drugs supported next year The new adjuvant hepatitis B vaccine of Watson biological (300142 SZ) has just been approved for clinical use The therapeutic double plasmid HBV DNA vaccine developed by Guangzhou Pharmaceutical (600332 SH) is waiting for the third phase of Unblinding, the cancer therapeutic vaccine of Haixin (600851 SH) (APDC for short) is in the third phase of clinical use, and the recombinant clotting factor product is a research project of Shanghai Laishi (002252 SZ).
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.